Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020)

Aim The aim of this official guideline, published and coordinated by the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Societies of Gynecology and Obstetrics in collaboration with the DMykG, DDG and AGII societies, was to provide consensus-based recommendations obtained by evaluating the relevant literature for the diagnosis, treatment and management of women with vulvovaginal candidosis. Methods This S2k guideline represents the structured consensus of a representative panel of experts with a range of different professional backgrounds commissioned by the Guideline Committee of the above-mentioned societies. Recommendations This guideline gives recommendations for the diagnosis, management, counseling, prophylaxis and screening of vulvovaginal candidosis.

Automated summary

This official guideline, coordinated by multiple gynecological and obstetrical societies in Germany, Austria, and Switzerland, aims to provide consensus-based recommendations for the diagnosis, treatment, and management of women with vulvovaginal candidosis. The structured consensus was obtained by evaluating relevant literature and represents the expertise of a panel of experts with diverse professional backgrounds. The guideline offers recommendations for diagnosis, management, counseling, prophylaxis, and screening of vulvovaginal candidosis.